TCL Archive Cancer Leadership Council Letter Calls For Permanent Leadership of NCI and FDA. November 22, 2006
TCL Archive The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data September 25, 1998
TCL Archive NCAB, DRCCA Board Asked To Consider Dripping All Staff Investigator Salary Support From Core October 17, 1980
TCL Archive FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs November 1, 1991